Repair Stem Cell Institute touts Grekos' breakthrough in Biomedical Technology
WASHINGTON, Nov. 5 /PRNewswire/ -- The Repair Stem Cell Institute (RSCI; http://www.RepairStemCells.org) today announced that its Science Advisory Board member Zannos G. Grekos, MD, FAAP will present Emerging Frontiers in Regenerative Stem Cell Therapy: Current Clinical Experience with Autologus Adult Stem Cells in the Treatment of Various End Stage Diseases, at the 2008 Dubai Congress on Anti-Aging and Aesthetic Medicine (DCAAAM) in Dubai, United Arab Emirates on Saturday, November 8, 2008 at 3:00 p.m. UTC. According to RSCI Chairman Don Margolis, "Dr. Grekos is taking his groundbreaking work in regenerative biomedical technology to an international arena that has never before seen the dramatic clinical success achieved with his end-stage disease patients. RSCI is proud to have Dr. Grekos on its advisory board and there isn't a company or an institute in the world with the Repair Stem Cell treatment skills and experience that he and its other members bring."
In this Dubai presentation, Dr. Grekos will illustrate regenerated tissue and repaired function at six months and one year post-treatment with Adult Stem Cells. He will also present preliminary results from patients treated within several days through three month follow up. Results include the existence of viable myocardium where previously heart tissue had been destroyed and blood flow through new vessels generated by the injected Stem Cell population. "We have literally saved the lives of patients who prior to the development of Adult Stem Cell therapy, had no option available to them through medical science," states Grekos. "With a minimally invasive treatment, the risks of which are equal to a cardiac catheterization, we are more than doubling cardiac patients' ejection fraction, improving kidney and pulmonary function, saving limbs from amputation by creating new circulation pathways and most recently reversing the life-threatening effects of metabolic heart disease."
Dr. Grekos plans to also announce upcoming clinical trials with prospective candidates in currently untreated illness classifications, including several neurologically based diseases and macular degeneration.
Dr. Zannos Grekos is an Interventional Cardiologist with a private practice in Florida. He is Chief Medical Officer for Regenocyte Therapeutic, one of the world's leading Adult Stem Cell centers, and is Associate Clinical Professor of Cardiology for Nova Southeastern University. Having collaborated with major international treatment and research centers, he has been active in the development of both research and treatment protocols. In February 2007, he was invited to Washington DC to brief the United States Senate Health Advisory Staff on the current state of stem cell research and therapy.
Paul Schwartz, Chief Operating Officer for Regenocyte Therapeutic, states the company "is extremely pleased with the invitation to speak in Dubai. It is a symbol," Schwartz explains, "of the worldwide medical community's embrace of Dr. Grekos' forging of new territory and the notoriety Regenocyte is rapidly gaining through its amazing treatment results."
About the Repair Stem Cell Institute
The Repair Stem Cell Institute LLC (RSCI) is a global public service firm dedicated to educating the public about repair stem cell/adult stem cell research and treatments worldwide. RSCI was founded in April 2008 and is headquartered in Bangkok, Thailand with offices in Dallas, Texas and Washington, D.C.
About Regenocyte Therapeutic
Regenocyte(TM) Therapeutic LLC is one of the only clinically treating Adult Stem Cell Therapy centers in the world today. An experienced team of Board Certified physicians use cutting edge technology, paralleling that of Universities and major medical facilities, to prolong and improve the quality of life of patients living with diseases including Congestive Heart Failure, Cardiomyopathy, Peripheral Artery Disease, Coronary Artery Disease, Kidney Disease, Ischemic Heart Disease, Pulmonary Disease and Early Senile Dementia. For patient information or consultation, call 866-216-5710.
|SOURCE The Repair Stem Cell Institute|
Copyright©2008 PR Newswire.
All rights reserved